We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SKIN:NASDAQSkinHealth Systems Inc. Analysis

Data as of 2026-08-31 - not real-time

$0.69

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $0.6914, SkinHealth Systems Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. Across the trailing 30 sessions it lost 12.3%. RSI sits at 51.0, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at $0.5670 up to resistance at $0.7800.
On valuation the read is undervalued — an earnings multiple of 3.6, absent a reliable peer benchmark. Consensus targets land 43.4% above where the shares trade now. Revenue is contracting at 7.8% on a -9.8% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 85.5%, a beta of 1.28 and a maximum drawdown of 77.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

SkinHealth Systems Inc. SKIN reported $72.1 million in revenue for the quarter ended June 2026, representing a...Skinhealth Systems Reports Second Quarter 2026 Financial Results.LONG BEACH, Calif., Aug. 06, 2026 GLOBE NEWSWIRE -- SkinHealth Systems Inc. NASDAQ: SKIN "SkinHealth Systems" or the...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.01
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.01
  • Analyst targets imply +43.4% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Negative profit margin of -9.8%
  • Analyst targets imply +43.4% versus the current price
  • Negative return on equity of -43.9%

Key Metrics & Analysis

Financial Health

Revenue Growth-7.80%
Profit Margin-9.80%
P/E Ratio3.6
ROE-43.89%
ROA-0.54%
Debt/Equity660.53
P/B Ratio1.6
Op. Cash Flow$22.0M
Free Cash Flow$27.5M

Technical Analysis

TrendBearish
RSI51.0
Support$0.57
Resistance$0.78
MA 20$0.67
MA 50$0.73
MA 200$1.01
MACDBullish
VolumeStable
Fear & Greed Index94.46

Valuation

Fair Value$1.46
Target Price$0.99
Upside/Downside43.43%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.28
Volatility85.48%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.